These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35815815)

  • 21. Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency.
    Zaninoni A; Marra R; Fermo E; Consonni D; Andolfo I; Marcello AP; Rosato BE; Vercellati C; Barcellini W; Iolascon A; Bianchi P; Russo R
    Sci Rep; 2023 Mar; 13(1):4395. PubMed ID: 36927785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.
    Wang J; Hayashi Y; Yokota A; Xu Z; Zhang Y; Huang R; Yan X; Liu H; Ma L; Azam M; Bridges JP; Cancelas JA; Kalfa TA; An X; Xiao Z; Huang G
    Haematologica; 2018 Jan; 103(1):40-50. PubMed ID: 29051279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia.
    Li Y; Miller I; Prasad P; George NA; Parrow NL; Fleming RE
    Front Physiol; 2022; 13():893149. PubMed ID: 35634155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2.
    Berezovsky B; Báječný M; Frýdlová J; Gurieva I; Rogalsky DW; Přikryl P; Pospíšil V; Nečas E; Vokurka M; Krijt J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia.
    Sochorcova L; Hlusickova Kapralova K; Fialova Kucerova J; Pospisilova D; Prochazkova D; Jahoda O; Kurekova S; Kralova B; Divoka M; Navratilova J; Manakova J; Kriegova E; Indrak K; Faber E; Divoky V; Horvathova M
    Br J Haematol; 2023 Aug; 202(3):674-685. PubMed ID: 37246471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.
    Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T
    Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.
    Mirciov CSG; Wilkins SJ; Hung GCC; Helman SL; Anderson GJ; Frazer DM
    Haematologica; 2018 Oct; 103(10):1616-1626. PubMed ID: 29903760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental Erythroferrone and Erythropoietin mRNA Expression is not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples.
    Delaney KM; Barad A; Castillo LF; Hasund CM; Guillet R; Pressman EK; Katzman PJ; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2023 Jul; 153(7):1950-1958. PubMed ID: 37253412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron Mining for Erythropoiesis.
    Correnti M; Gammella E; Cairo G; Recalcati S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mutual crosstalk between iron and erythropoiesis.
    Camaschella C; Pagani A; Silvestri L; Nai A
    Int J Hematol; 2022 Aug; 116(2):182-191. PubMed ID: 35618957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythroferrone inhibits the induction of hepcidin by BMP6.
    Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.
    Rybinska I; Cairo G
    Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
    Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
    PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythroferrone contributes to iron mobilization for embryo erythropoiesis in iron-deficient mouse pregnancies.
    Sangkhae V; Yu V; Coffey R; O'Brien KO; Ganz T; Nemeth E
    Am J Hematol; 2022 Oct; 97(10):1348-1358. PubMed ID: 36071577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
    Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
    Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
    Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
    J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
    Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat.
    Ribeiro S; Garrido P; Fernandes J; Rocha S; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Blood Cells Mol Dis; 2016 Jul; 59():63-70. PubMed ID: 27282570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of erythroferrone as an erythroid regulator of iron metabolism.
    Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
    Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.